TISSUE & FFPE COHORT COLLECTIONS
Ovarian cancer tissue microarrays & FFPE blocks
Compare ovarian cancer tissue arrays by histology and available records, including selected serous collections and tissue with matched plasma. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Ovarian cancer arrays (18)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
IO Multi tumor array 2 of a set of 6 TMAs : Prostate ADC, HRPC/CRPC, Endometrial, Ovarian, Cervical, RCC with histopath data. 1x1mm core each from tumor & invasive edge (TA3125)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array 2 of a set of 4 TMAs : Pancreatic, Ovarian, Gastric, Head & Neck SCC, Melanoma, Bladder (UC) with histopath data (TA2996)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising breast, bladder(uc), ovarian, lung, prostate, melanoma, RCC , head & neck SCC, CRC, pancreatic ADC with histopath data (TA4340)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising cores with high immune infiltrates from NSCLC, Bladder(UC), Ovarian, Gastric & RCC. TMA1 of a set of 2 TMAs, histopath data (TA4312)
- Approx. cores
- 120
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4321)
- Approx. cores
- 124
- Approx. donors
- 64
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4331)
- Approx. cores
- 110
- Approx. donors
- 69
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4341)
- Approx. cores
- 45
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Ovarian cancer (HG & LG serous, endometroid, clear cell, mucinous) with follow up data; sub-set with BRCA mutation status (TA3166)
- Approx. cores
- 144
- Approx. donors
- 144
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
Ovarian cancer (platinum resistant ) pre-treatment with follow up data (TA4358)
- Approx. cores
- 55
- Approx. donors
- 55
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Ovarian Cancer (serous) with follow up data (TA1966)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Ovarian cancer post-treatment (platinum resistant) with follow up data (TA4359)
- Approx. cores
- 55
- Approx. donors
- 55
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Ovarian cancer pre and post platinum treatment (not donor matched) with follow up data (TA4326)
- Approx. cores
- 75
- Approx. donors
- 75
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Not listed
Ovarian cancer with platinum therapy follow up information, pre treatment, post treatment (not donor matched), subset with BRCA status (TA4346)
- Approx. cores
- 144
- Approx. donors
- 144
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
Ovarian cancer with platinum therapy follow up information, pre treatment, post treatment (not donor matched), subset with BRCA status (TA4347)
- Approx. cores
- 144
- Approx. donors
- 144
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
IllustrationRNAscope pre-qualified multi tumor array 120 cores total, 1mm core diameter – (same as previous TA4380) (TA4388)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array, 2mm core diameter, TMA1 of a set of 2 TMAs, histopath data (TA3117)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
TMA block comprising the following tumor types with histopathology data (Endometrial (25), Esophageal (30), Gastric (30) and Ovarian (60) (TA4497)
- Approx. cores
- 145
- Approx. donors
- 145
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, prostate ADC, HRPC, ovarian, endometrial, RCC, cervical, (TA3109)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Ovarian cancer FFPE blocks for your study
Ovarian cohorts with serous histology, platinum-treatment information, selected BRCA status or matched plasma.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Ovarian cancer FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #150
Ovarian Cancer (serous) with follow up data
Cohort #151
Ovarian cancer (HG & LG serous, endometrioid, clear cell, mucinous) with follow up data; sub-set with BRCA mutation status
Cohort #152
Ovarian cancer (platinum resistant) pre-treatment with follow up data
Cohort #153
Ovarian cancer post-treatment (platinum resistant) with follow up data
Cohort #184
Ovarian cancer with matched double spun plasma
Cohort #155
Ovarian cancer with platinum therapy follow up information, pre treatment, post treatment (not donor matched), subset with BRCA status
Ovarian cancer · Patient profile
BRCA wild-type or BRCA-mutated advanced disease
Ovarian cancer · Patient profile
HER2 IHC 3+, 2+ or 1+ advanced high-grade epithelial disease
Ovarian cancer · Patient profile
Platinum-resistant or platinum-sensitive disease
Ovarian cancer · Patient profile
Recurrent ovarian cancer
SELECTING YOUR ARRAY
Selecting ovarian cancer tissue for your study
Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.
TA1966 tissue composition
Ovarian Cancer (serous) with follow up data (TA1966).
TA3166 tissue composition
Ovarian cancer (HG & LG serous, endometroid, clear cell, mucinous) with follow up data; sub-set with BRCA mutation status (TA3166).
TA4326 tissue composition
Ovarian cancer pre and post platinum treatment (not donor matched) with follow up data (TA4326).